Kosyakovsky, Leah B. https://orcid.org/0000-0003-2482-0444
de Boer, Rudolf A. https://orcid.org/0000-0002-4775-9140
Ho, Jennifer E. https://orcid.org/0000-0002-7987-4768
Article History
Accepted: 4 September 2024
First Online: 17 September 2024
Declarations
: Dr. Kosyakovsky is supported by the National Institutes of Health (NIH) T32-HL160522. Dr. Ho is supported by grants from the NIH R01-HL160003, R01-HL168889, and K24-HL153669. Dr. de Boer is supported by the Netherlands Heart Foundation (grants 2018–30; 2020B005; 01–003-2022–0358) and the ERC (CoG 818715).The authors declare no interests that are directly or indirectly related to the work submitted for publication; the authors did not receive support from any organization for the submitted work.The institution of Dr. de Boer has received research grants and/or fees from AstraZeneca, Abbott, Bristol-Myers Squibb, Cardior Pharmaceuticals GmbH, NovoNordisk, and Roche. Dr. de Boer has had speaker engagements with and/or received fees from and/or served on an advisory board for Abbott, AstraZeneca, Bristol Myers Squibb, Cardior Pharmaceuticals GmbH, NovoNordisk, and Roche. Dr. de Boer received travel support from Abbott, Cardior Pharmaceuticals GmbH, and NovoNordisk.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: The authors declare no competing interests.